BRAF and metastatic neoplasm: Even after adjusting for other factors such as BRAF status, treatment type and time to diagnosis of metastatic disease, the cutoff of ≥2 CTCs/7.5 mL remained a significant poor prognostic factor (p = 0.005) [164].